Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Obesity and type 2 diabetes impair mRNA COVID vaccine efficacy in mouse model

In a recent study posted to bioRxiv*, researchers in the United States assessed the impact of metabolic diseases on coronavirus disease 2019 (COVID-19) vaccine immunogenicity in a mouse model.

13 Dec 2022

Caffeinated coffee consumption linked to lower risk of T2D among women with history of gestational diabetes

The prevalence of type 2 diabetes is projected to continue rising and one in three Singaporeans currently has a risk of developing diabetes in their lifetime. Several early-life cardiometabolic complications make identifying high-risk populations and application of diabetes preventive strategies paramount.

13 Dec 2022

Extremely hot and cold temperatures linked with higher risk of cardiovascular deaths

Extremely hot and cold temperatures both increased the risk of death among people with cardiovascular diseases, such as ischemic heart disease (heart problems caused by narrowed heart arteries), stroke, heart failure and arrhythmia, according to new research published today in the American Heart Association's flagship journal Circulation.

13 Dec 2022

Virginia Tech researchers receive three grants to study the effects of ultra-processed foods

Scientists in the Virginia Tech College of Agriculture and Life Sciences are investigating the effects of ultra-processed foods on the human body using a variety of research tools.

13 Dec 2022

Study provides new insights for the future development of oral insulin pill

WEHI researchers in Melbourne have answered a 100-year-old question in diabetes research: can a molecule different to insulin have the same effect? The findings provide important insights for the future development of an oral insulin pill.

12 Dec 2022

$Forxiga (dapagliflozin) approved in Great Britain for symptomatic chronic heat failure across the full spectrum of left ventricular ejection fraction$

Forxiga (dapagliflozin) approved in Great Britain for symptomatic chronic heat failure across the full spectrum of left ventricular ejection fraction

AstraZeneca today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a licence extension for dapagliflozin in Great Britain for the treatment of symptomatic chronic heart failure (HF) in patients with HF and a left ventricular ejection fraction (LVEF) >40%, including HF with mildly reduced ejection fraction (HFmrEF) and preserved ejection fraction (HFpEF).

From AstraZeneca 12 Dec 2022

Study of 1.1 million children finds no association between SARS-CoV-2 infection and type 1 diabetes risk

Researchers investigate whether the risk of new-onset type 1 diabetes is elevated by SARS-CoV-2 infections among children living in Denmark.

11 Dec 2022

Complementary, alternative therapies for heart failure have some benefits and potential risks

There are some benefits and potentially serious risks when people with heart failure use complementary and alternative medicines (CAM), to manage symptoms, so involving the health care team is important for safety, according to a new American Heart Association scientific statement published today in the Association's flagship, peer-reviewed journal Circulation.

8 Dec 2022

Antibodies against gentamicin associated with increased risk of type 1 diabetes in children

Antibodies produced against the commonly used antibiotic, gentamicin, appear to increase the risk of type 1 diabetes in children already genetically at risk, scientists say.

8 Dec 2022

Study explores the risk of new-onset diabetes mellitus following SARS-CoV-2 infections

Researchers evaluated individuals who had SARS-CoV-2 infections and were diagnosed with diabetes mellitus within six months of the onset of COVID-19 to understand the temporal relationship between SARS-CoV-2 infections and diabetes mellitus.

8 Dec 2022

New Clinical Practice Guideline offers recommendations to manage hypoglycemia in people with diabetes

People with diabetes are benefiting from advances in medications and technologies to lower their risk of hypoglycemia, according to a Clinical Practice Guideline issued today by the Endocrine Society.

7 Dec 2022

Study allows people with type 2 diabetes to choose their own medication

A large-scale new study offers a new approach to treating type 2 diabetes - that puts patients in charge of their own medication. The Trimaster study is the first to allow people with type 2 diabetes to choose their own medication, after trying three different drugs in succession.

7 Dec 2022

Researchers identify micronutrient supplementation to reduce cardiovascular risk

Healthy diets are rich in antioxidants like amino acids, omega-3 fatty acids and vitamin C, but exactly how beneficial these micronutrients are for cardiovascular health has long been controversial.

6 Dec 2022

Consistent exercise linked to beneficial epigenetic changes, twin-study shows

Consistent exercise can change not just waistlines but the very molecules in the human body that influence how genes behave, a new study of twins indicates.

6 Dec 2022

Parkinson’s drug improves blood pressure, aortic stiffness in adolescents with Type 1 diabetes

Teens with Type 1 diabetes (T1D) who took bromocriptine, a medication used to treat Parkinson's disease and Type 2 diabetes, had lower blood pressure and less stiff arteries after one month of treatment compared to those who did not take the medicine, according to a small study published today in Hypertension, an American Heart Association journal.

6 Dec 2022

Financial incentives effective in boosting weight loss among low-income populations

Paying cash to people with obesity for losing a specific amount of weight or completing weight-reducing activities works better than offering stand-alone free tools, such as weight-loss programs, diet books, and wearable fitness trackers, a new study shows.

5 Dec 2022

Discovery offers an avenue for development of novel therapies for Chagas disease

Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, affects some 8 million people worldwide. More than a third develop severe heart or digestive problems with a heightened risk of death.

5 Dec 2022

Trial aims to make it easier, convenient for patients to perform health checks and reduce pressure on GPs

A landmark trial aiming to make it easier and more convenient for patients to carry out important health checks and reduce pressure on GPs has been launched in Cornwall.

5 Dec 2022

Adoption of front-of-pack nutrition labeling in the Americas can help reduce poor-nutrition related NCDs

The adoption of best practice front-of-pack nutrition labeling in more countries of the Americas can help reduce poor-nutrition related non-communicable diseases (NCDs) such as cardiovascular disease, type-2 diabetes, high blood pressure and some cancers in the region, a recent study led by researchers at the University of Nevada, Reno and the Pan American Health Organization suggests.

2 Dec 2022

Klick scientists use machine learning and 12 hours of CGM data to predict diabetes onset

Scientists at Klick Applied Sciences have discovered a way to transform a continuous glucose monitor (CGM) into a powerful diabetes screening and prevention tool using artificial intelligence.

2 Dec 2022

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Obesity and type 2 diabetes impair mRNA COVID vaccine efficacy in mouse model

Caffeinated coffee consumption linked to lower risk of T2D among women with history of gestational diabetes

Extremely hot and cold temperatures linked with higher risk of cardiovascular deaths

Virginia Tech researchers receive three grants to study the effects of ultra-processed foods

Study provides new insights for the future development of oral insulin pill

Forxiga (dapagliflozin) approved in Great Britain for symptomatic chronic heat failure across the full spectrum of left ventricular ejection fraction

Study of 1.1 million children finds no association between SARS-CoV-2 infection and type 1 diabetes risk

Complementary, alternative therapies for heart failure have some benefits and potential risks

Antibodies against gentamicin associated with increased risk of type 1 diabetes in children

Study explores the risk of new-onset diabetes mellitus following SARS-CoV-2 infections

New Clinical Practice Guideline offers recommendations to manage hypoglycemia in people with diabetes

Study allows people with type 2 diabetes to choose their own medication

Researchers identify micronutrient supplementation to reduce cardiovascular risk

Consistent exercise linked to beneficial epigenetic changes, twin-study shows

Parkinson’s drug improves blood pressure, aortic stiffness in adolescents with Type 1 diabetes

Financial incentives effective in boosting weight loss among low-income populations

Discovery offers an avenue for development of novel therapies for Chagas disease

Trial aims to make it easier, convenient for patients to perform health checks and reduce pressure on GPs

Adoption of front-of-pack nutrition labeling in the Americas can help reduce poor-nutrition related NCDs

Klick scientists use machine learning and 12 hours of CGM data to predict diabetes onset

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in